Aperio Group’s HUTCHMED HCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-25,854
Closed -$835K 2440
2020
Q3
$835K Buy
25,854
+2,120
+9% +$66.1K ﹤0.01% 1534
2020
Q2
$655K Sell
23,734
-1,673
-7% -$36.3K ﹤0.01% 1630
2020
Q1
$454K Sell
25,407
-1,646
-6% -$39.7K ﹤0.01% 1703
2019
Q4
$678K Buy
27,053
+10,951
+68% +$240K ﹤0.01% 1644
2019
Q3
$287K Buy
16,102
+13,812
+603% +$288K ﹤0.01% 2037
2019
Q2
$50K Buy
+2,290
New +$65.4K ﹤0.01% 2530

Other funds holding HCM

Aperio Group's HCM Position: Q4 2020 in Review

Aperio Group sold out of HUTCHMED (HCM) in Q4 2020, closing a stake of 25,854 shares — an estimated $835K sold.

Aperio Group first reported a position in HCM in Q2 2019 and held it in 6 quarters. The position peaked at $835K in Q3 2020. 130 funds tracked by Wall St. Rank hold HCM as of Q4 2020.

  • Aperio Group reported no remaining HUTCHMED position as of Q4 2020 after selling out during the quarter.
  • Aperio Group sold 25,854 HUTCHMED shares in Q4 2020, an estimated $835K.
  • Aperio Group first reported a position in HUTCHMED in Q2 2019 and held it in 6 quarters.
  • Aperio Group's HUTCHMED position peaked at $835K in Q3 2020.
  • 130 funds tracked by Wall St. Rank held HUTCHMED as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.